Alembic Limited NSE India S.E.

Equities

ALEMBICLTD

INE426A01027

Real Estate Development & Operations

Market Closed - NSE India S.E. Other stock markets 07:43:47 2024-04-19 am EDT			5-day change	1st Jan Change
92.7 ^INR	+1.64%		-3.74%	+2.43%

Apr. 18	Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%	MT
Apr. 02	Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	MT

Alembic : Board Meeting Notice-English-30.10.2017

October 30, 2017 at 07:48 am EDT

, THE INDIAN EXPRESS, THURSDAY ,OCTOBER 19,2017

GUJARAT

I" •

f A.l!!',:!J!>[F)

ALEMBIC LIMITED

Regd. Office: Alembic Road, ladodara •390003

CIN: L26100GJ1907PLC000033

Te!:026&-2280550,Fax: 2282506

Email:alembic.investors@alembic.co.in

Website:www.alembidimited.com

NOTICE

NOTICE is hereby given pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Ragulations, 2015, that a meeting of the Board of Directors of the Company will be held on Monday, 30th October, 2017, inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September,2017.

For Alembic Limited

Drigesh Mlttal

Company Secretary

Place: Vadodara

Date: 18th October, 2017

The Noticeis also available at Investors Section of the Company's website . www.alembiclimited.comand Corporate Announcement Section of Stock Exchange's website www.nselndia.com

andwww.bseindia.com

Alembic Limited published this content on 30 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 30 October 2017 11:47:05 UTC.

Original documenthttp://www.alembiclimited.com/notice/Alembic Limited Board Meeting Notice-English-30.10.2017.pdf

Public permalinkhttp://www.publicnow.com/view/5BF6FD90C7EFDB8EF13B61CA4626462B90888F49

Latest news about Alembic Limited

Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%	Apr. 18	MT
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	Apr. 02	MT
Alembic Limited Announces Cessation of C. P. Buch as an Independent Director	Apr. 01	CI
Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA	Mar. 11	MT
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook	Mar. 08	MT
ICRA Affirms AA- Rating on Alembic's Bank Financing; Outlook Stable	Feb. 29	MT
Indian shares seen muted tracking broader Asian equities	Feb. 25	RE
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India	Feb. 23	MT
Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates	Feb. 06	MT
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates	Feb. 06	MT
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	Feb. 05	RE
North American Morning Briefing : Jobs Report Tops -2-	Feb. 02	DJ
North American Morning Briefing : Microsoft Kicks -2-	Jan. 30	DJ
North American Morning Briefing : Stock Futures -2-	Jan. 23	DJ
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months	Jan. 05	MT
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit	Jan. 02	MT
North American Morning Briefing : Stock Futures -2-	Nov. 16	DJ
Alembic Pharmaceuticals Logs Slightly Higher Consolidated Profit in Fiscal Q2; EPS Misses Estimates	Nov. 08	MT
India's Alembic Pharma Q2 profit roughly in-line with estimates	Nov. 07	RE
North American Morning Briefing : Stocks Look to -2-	Nov. 06	DJ
Alembic Limited Appoints Dr. Girish Hirode as an Independent Director of the Company	23-08-10	CI
Alembic Limited Announces Company Secretary & Compliance Officer Changes	23-08-10	CI
Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI

Chart Alembic Limited

Duration

Period

More charts

Company Profile

Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.

Sector

Real Estate Development & Operations

Calendar

2024-05-15 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Real Estate Development & Operations

	1st Jan change	Capi.
MITSUI FUDOSAN CO., LTD.	+36.25%	29.25B
SUN HUNG KAI PROPERTIES LIMITED	-17.11%	25.9B
DLF LIMITED	+17.79%	25.36B
MITSUBISHI ESTATE CO., LTD.	+44.00%	23.09B
CHINA RESOURCES LAND LIMITED	-16.07%	21.67B
EMAAR PROPERTIES	+4.67%	20.17B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	+29.30%	16.98B
CHINA OVERSEAS LAND & INVESTMENT LTD.	-16.28%	16.07B
SM PRIME HOLDINGS, INC.	-17.02%	14.15B

Other Real Estate Development & Operations